CLASS II Device recall · Reported 19 Dec 2018 · FDA Enforcement Report

Cascade Abrazo c-Act-lr Test Card Ivd For IN Vitro recalled

Helena Laboratories is recalling Cascade Abrazo c-Act-lr Test Card Ivd For IN Vitro Diagnostic Use Store at 2 to 8 C, distributed nationwide in the US. The recall was initiated on 20 Apr 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Codes: 1-15-5701 Model/Catalog Number: 5701
Quantity recalled12 Kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0594-2019
FDA event ID
81356
Recalling firm
Helena Laboratories, Beaumont, TX
Classification
Class II
Status
Terminated
Recall initiated
20 Apr 2016
FDA classified
10 Dec 2018
Reported
19 Dec 2018
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons
Device type
Patient Monitors

Timeline

20 Apr 2016Recall initiated by company
10 Dec 2018Classified by FDA+964 days
19 Dec 2018Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to some cards in this lot experiencing variations in wave form, resulting in some cards with shorter or longer times than expected

Product as listed by the FDA

Cascade Abrazo c-ACT-LR Test Card IVD FOR IN VITRO DIAGNOSTIC USE Store at 2 to 8 C HELENA LABORATORIES 003366 12/13(2) FOR EXPORT ONLY The Cascade Abrazo c-ACT-LR test cards are activated clotting time tests to be used with the Cascade Abrazo analyzer and are intended to monitor the effect of low to moderate heparin on coagulation in fresh whole blood.

Where it was distributed

US Distribution to state of TX and internationally to: Australia, Netherlands, Italy, and England.

Nationwide Texas

Questions about this recall

Why was it recalled?

Due to some cards in this lot experiencing variations in wave form, resulting in some cards with shorter or longer times than expected

Which lots are affected?

Lot Codes: 1-15-5701 Model/Catalog Number: 5701

Where was it sold?

US Distribution to state of TX and internationally to: Australia, Netherlands, Italy, and England.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Helena Laboratories

All 16

Other Patient Monitors recalls

All 1,013